Patheon Unveils New Brand and Identity
News Oct 03, 2015
Patheon has unveiled its new brand identity, reflecting the company’s leadership position in the pharmaceutical services industry, and the difference it makes in the lives of patients.
The new brand positioning centers around an updated brand promise based on the fundamental belief; the world would be a healthier place if tomorrow’s medicines were made available today. The branding elements include a creative visual system, an updated logo and a new company tag line that together represent how the company is differentiated, compelling and best-equipped to help address client challenges.
A Healthier World. Delivered.™
The new tag line promises a healthier world, and is meant to reflect the company’s commitment to working closely with clients to help them find solutions to some of their greatest formulation development and manufacturing challenges.
“People around the world depend on life-changing medications from pharmaceutical companies and Patheon is delivering those medications every day through its dedicated workforce,” said Chris Tama, senior vice president of marketing. “Our new brand platform promotes our leadership position, the work our employees perform around the world and the fact that we are uniquely positioned to provide end-to-end pharmaceutical development and manufacturing services under a single, master brand.”
The Maker’s Hand
The visual of a working hand represents the Patheon employees who make and deliver life-changing medicines to patients waiting for them. The image captures trust and partnership, and insights gained through years of experience and the highest level of expertise to efficiently deliver better performance, care and quality.
A completely redesigned website revealing the modern new design has also been launched as part of the rebranding exercise, with the new visuals clearly and effectively communicating the company’s differentiators and value proposition. The promotion will be part of a global effort to help current and prospective clients better understand how Patheon can help address the most complex development and manufacturing needs.
The new brand will be applied to all promotional materials and communication channels, and rolled out behind a global promotional campaign in publications and trade journals, along with digital brochures and sales tools. The brand was first unveiled to Patheon’s most valuable asset - its employees - who are represented by the maker’s hand.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018